ORGANIZATION

• Think Tanks Urge Unique Value Framework for Regenerative Medicine in 2026 Reform
  October 2, 2025

• JETRO Launches Japan Entry Program for Regenerative Medicine Startups
  October 2, 2025

• Policy Veterans’ Group Calls for Inflation-Linked Drug Pricing in FY2026 Reform
  October 1, 2025

• Generic Use Rate Hits Record 89.2% in April-June: JGA
  September 29, 2025

• Kenporen Proposes Higher Copays for Choosing Costlier Drugs
  September 26, 2025

• Japan Wholesalers’ Profit Margin Improves to 1.11% in FY2024
  September 26, 2025

• JPMA Think Tank Chief Pledges to Back Policy Debates with Evidence
  September 26, 2025

• Japanese Pharma-Cosmetic Union Breaks from UA Zensen, Set to Join Rengo
  September 25, 2025

• JPMA to Overhaul Guideline for Handling Drug Inquiries This Fall: Consultation Chair
  September 25, 2025

• Generic Use Rate at 89.6% in April: Payer
  September 25, 2025

• JPMA Publishes TPP Overview to Bridge Academia and Industry: R&D Chair
  September 22, 2025

• JPMA Sets Up Multilateral Advocacy Group to Bolster Global Voice: International Affairs Chair
  September 19, 2025

• JPMA Launches Task Force on AI and Open Innovation Challenges: IP Chief
  September 18, 2025

• JPMA to Broaden Base of Biopharma Talent through On-Site Training: Committee Chair
  September 17, 2025

• JPMA to Compile Best Practices on Patient and Public Involvement
  September 16, 2025

• JPMA Names Ex-MHLW Pharma Official Yoshida as Senior Managing Director
  September 12, 2025

• JPMA Plans Joint Training with HCPs to Improve Promo Materials: Review Board Chair
  September 11, 2025

• JPMA to Step Up Public Outreach, Build Understanding of Pharma, Says PR Head
  September 10, 2025

• JPMA Quality Committee Launches Task Force on DX in Commercial Production
  September 9, 2025

• JPMA Code & Compliance Chair Stresses Need to Embed Spirit of Revised COP
  September 8, 2025

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »